Factors associated with progression of depression, anxiety, and stress-related symptoms in outpatients and inpatients with COVID-19: A longitudinal study

dc.contributor.authorAlici, Yasemin Hosgoren
dc.contributor.authorCinar, Gule
dc.contributor.authorHasanli, Jamal
dc.contributor.authorCeran, Selvi
dc.contributor.authorOnar, Deha
dc.contributor.authorGulten, Ezgi
dc.contributor.authorKalkan, Irem Akdemir
dc.contributor.authorMemikoglu, Kemal Osman
dc.contributor.authorCelik, Casit Olgun
dc.contributor.authorDevrimci-Ozguven, Halise
dc.contributor.orcID0000-0003-3384-8131en_US
dc.contributor.orcID0000-0003-1364-625Xen_US
dc.contributor.orcID0000-0002-7984-2440en_US
dc.contributor.orcID0000-0002-7190-5443en_US
dc.contributor.pubmedID35593144en_US
dc.contributor.researcherIDAAJ-8113-2021en_US
dc.contributor.researcherIDAAK-3227-2021en_US
dc.contributor.researcherIDAAD-5477-2021en_US
dc.date.accessioned2022-12-12T10:27:13Z
dc.date.available2022-12-12T10:27:13Z
dc.date.issued2022
dc.description.abstractIt is known that there is an increase in the frequency of psychiatric disturbances in the acute and post-illness phase of coronavirus disease (COVID-19). Comorbid psychiatric symptoms complicate the management of patients and negatively affect the prognosis, but there is no clear evidence of their progress. We aimed to determine psychiatric comorbidity in inpatients and outpatients with COVID-19 and recognize the factors that predict psychiatric comorbidity. For this purpose, we evaluated patients on the first admission and after 4 weeks. We investigated psychiatric symptoms in outpatients (n = 106) and inpatients (n = 128) diagnosed with COVID-19. In the first 7 days after diagnosis (first phase), sociodemographic and clinic data were collected, a symptom checklist was constructed, and the Hospital Anxiety and Depression Scale (HADS) and the Severity of Acute Stress Symptoms Scale (SASSS) were applied. After 30-35 days following the diagnosis, the SASSS and the HADS were repeated. In the first phase, the frequency of depression and anxiety were 55% and 20% in inpatients, and 39% and 18% in outpatients, respectively. In the second phase, depression scores are significantly decreased in both groups whereas anxiety scores were decreased only in inpatients. The frequencies of patients reporting sleep and attention problems, irritability, and suicide ideas decreased after 1 month. Patients with loss of smell and taste exhibit higher anxiety and depression scores in both stages. Our results revealed that the rate of psychiatric symptoms in COVID-19 patients improves within 1 month. Inpatients have a more significant decrease in both depression and anxiety frequency than do outpatients. The main factor affecting anxiety and depression was the treatment modality. Considering that all patients who were hospitalized were discharged at the end of the first month, this difference may be due to the elimination of the stress caused by hospitalization.en_US
dc.identifier.endpage559en_US
dc.identifier.issn2046-0252en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85130258277en_US
dc.identifier.startpage550en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347536/pdf/PCHJ-11-550.pdf
dc.identifier.urihttp://hdl.handle.net/11727/8262
dc.identifier.volume11en_US
dc.identifier.wos000797829500001en_US
dc.language.isoengen_US
dc.relation.isversionof10.1002/pchj.557en_US
dc.relation.journalPSYCH JOURNALen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectanxietyen_US
dc.subjectCOVID-19en_US
dc.subjectdepressionen_US
dc.subjectmental healthen_US
dc.subjectpsychopathologyen_US
dc.titleFactors associated with progression of depression, anxiety, and stress-related symptoms in outpatients and inpatients with COVID-19: A longitudinal studyen_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ds188.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: